Steward Partners Investment Advisory, LLC Arcutis Biotherapeutics, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $11 Billion
- Q4 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 200 shares of ARQT stock, worth $3,098. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$3,098
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARQT
# of Institutions
218Shares Held
129MCall Options Held
2.02MPut Options Held
202K-
Jennison Associates LLC12.3MShares$191 Million0.11% of portfolio
-
Suvretta Capital Management, LLC New York, NY11.4MShares$177 Million6.61% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$170 Million2.52% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$136 Million7.34% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$134 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $932M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...